This clinical trial is designed to evaluate a new treatment option. Participants will be monitored to assess the effectiveness and safety of the treatment. The trial aims to gather data that could lead to improved patient care.
- Who Can Participate: Individuals aged 18-65 with a diagnosis of the condition being studied
- Study Details: Participants will receive either the new treatment or a placebo, which is a substance with no active ingredients, to compare outcomes
- Study Timelines and Visits: The study will last 6 months.The study requires 5 visits